NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-09-14
DOI
10.1161/circresaha.121.319153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-1 Beta–Mediated Sex Differences in Kawasaki Disease Vasculitis Development and Response to Treatment
- (2020) Rebecca A. Porritt et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Kawasaki disease: pathophysiology and insights from mouse models
- (2020) Magali Noval Rivas et al. Nature Reviews Rheumatology
- Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
- (2019) Dvir Aran et al. NATURE IMMUNOLOGY
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species
- (2019) Rapolas Zilionis et al. IMMUNITY
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- MCC950 closes the active conformation of NLRP3 to an inactive state
- (2019) Ana Tapia-Abellán et al. Nature Chemical Biology
- Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data
- (2019) Samuel L. Wolock et al. Cell Systems
- Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation
- (2019) Ploingarm Petsophonsakul et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis
- (2019) Robert C. Wirka et al. NATURE MEDICINE
- Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation
- (2019) Magali Noval Rivas et al. IMMUNITY
- The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction
- (2019) Rifeng Gao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
- (2019) Lieselotte Vande Walle et al. PLOS BIOLOGY
- Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease
- (2019) Fumiya Anzai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm
- (2018) Marie-Paule Guillaume et al. CARDIOLOGY IN THE YOUNG
- Severe Late-Onset Kawasaki Disease Successfully Treated With Anakinra
- (2018) Gauthier Blonz et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Bias, robustness and scalability in single-cell differential expression analysis
- (2018) Charlotte Soneson et al. NATURE METHODS
- Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease
- (2018) Preeti Jaggi et al. PLoS One
- MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
- (2018) Agampodi Promoda Perera et al. Scientific Reports
- Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience
- (2018) Shannon M. Skochko et al. JOURNAL OF PEDIATRICS
- Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature
- (2018) Victoria J. Wright et al. JAMA Pediatrics
- Dimensionality reduction for visualizing single-cell data using UMAP
- (2018) Etienne Becht et al. NATURE BIOTECHNOLOGY
- Interleukin-18: Biological properties and role in disease pathogenesis
- (2017) Gilles Kaplanski IMMUNOLOGICAL REVIEWS
- Histopathological aspects of cardiovascular lesions in Kawasaki disease
- (2017) Kei Takahashi et al. International Journal of Rheumatic Diseases
- Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
- (2017) Hua Jiang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity
- (2017) Martina Molgora et al. NATURE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD8+ T Cells Contribute to the Development of Coronary Arteritis in theLactobacillus caseiCell Wall Extract-Induced Murine Model of Kawasaki Disease
- (2017) Magali Noval Rivas et al. Arthritis & Rheumatology
- Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease
- (2017) Jane C. Burns et al. Arthritis & Rheumatology
- Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease–Associated Abdominal Aortic AneurysmSignificance
- (2016) Daiko Wakita et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial)
- (2016) Adriana H. Tremoulet et al. Contemporary Clinical Trials
- Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease
- (2016) Martin Prince Alphonse et al. JOURNAL OF IMMUNOLOGY
- Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
- (2016) P. L. Stahl et al. SCIENCE
- IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse ModelSignificance
- (2015) Youngho Lee et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
- (2015) Jane C Burns et al. Expert Review of Clinical Immunology
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Epidemiology of Immunoglobulin Resistant Kawasaki Disease: Results from a Large, National Database
- (2014) Brady S. Moffett et al. PEDIATRIC CARDIOLOGY
- Single-Nucleotide Polymorphism rs7251246 in ITPKC Is Associated with Susceptibility and Coronary Artery Lesions in Kawasaki Disease
- (2014) Ho-Chang Kuo et al. PLoS One
- Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease
- (2014) Long Truong Hoang et al. Genome Medicine
- Interleukin-1β Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki Disease
- (2012) Youngho Lee et al. CIRCULATION
- Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms
- (2012) Matthew R. Alexander et al. PHYSIOLOGICAL GENOMICS
- Three Linked Vasculopathic Processes Characterize Kawasaki Disease: A Light and Transmission Electron Microscopic Study
- (2012) Jan Marc Orenstein et al. PLoS One
- Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice
- (2011) Matthew R. Alexander et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-1B Polymorphism in Association With Initial Intravenous Immunoglobulin Treatment Failure in Taiwanese Children With Kawasaki Disease
- (2010) Ken-Pen Weng et al. CIRCULATION JOURNAL
- Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance
- (2010) Wen Fury et al. HUMAN IMMUNOLOGY
- IL-1 pathways in inflammation and human diseases
- (2010) Cem Gabay et al. Nature Reviews Rheumatology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started